Hippocratic AI Partners with Nurses on Boards Coalition to Empower Nurses in Healthcare Tech
Hippocratic AI, the company developing the first safety-focused Large Language Model (LLM) for healthcare, has announced a strategic partnership with the Nurses on Boards Coalition (NOBC) to empower nurses in healthcare technology. This partnership reflects Hippocratic AI’s commitment to fostering…
Novocure Announces PANOVA-3 Phase 3 Trial Results for TTFields in Pancreatic Cancer
Novocure (NASDAQ: NVCR) announced that its pivotal Phase 3 PANOVA-3 trial successfully met its primary endpoint, showing a statistically significant improvement in median overall survival (mOS) compared to the control arm. The trial assessed the combination of Tumor Treating Fields…
Agiliti Unveils New Adapt Line™ of Therapeutic Support Surfaces for Enhanced Comfort and Outcomes
Agiliti, a leading provider of medical device solutions, has announced the launch of its new Adapt Line™ of therapeutic hospital support surfaces. These surfaces are clinically designed to improve patient comfort and reduce the risk of pressure injuries caused by…
Flatiron Health to Present Research at San Antonio Breast Cancer Symposium 2024
Flatiron Health today announced its participation in the upcoming San Antonio Breast Cancer Symposium (SABCS), with four accepted abstracts for poster presentation. Additionally, the company will sponsor a session titled “How Holistic Real-World Evidence Generation Advances Breast Cancer Research.” “We…
Almirall Launches The Hive, a New Innovation Hub for Life Sciences
Almirall, a global pharmaceutical company focused on medical dermatology, today unveiled “The Hive,” a groundbreaking scientific research hub located at its R&D center in Barcelona, Spain. The Hive is designed to promote collaboration among researchers from biotech companies, start-ups, academia,…
Carlsmed Receives FDA Clearance for aprevo® Cervical Fusion Device
Carlsmed, Inc., a MedTech company specializing in AI-driven personalized spine surgery, today announced that it has received FDA 510(k) clearance for the aprevo® Cervical ACDF Interbody System. This achievement highlights Carlsmed’s dedication to advancing patient-specific spine surgery solutions aimed at…
Covenant Behavioral Health Gets Grant to Enhance ADHD Care for Military Families
Covenant Behavioral Health, a leading healthcare provider for active-duty personnel, veterans, and their families, has received the inaugural grant from Qbtech’s new QbAccess program. This initiative is designed to offer non-profit healthcare organizations access to Qbtech’s FDA-cleared objective ADHD testing…
UK MHRA Grants Innovation Passport to ILiAD Biotech’s BPZE1 Intranasal Pertussis Vaccine
ILiAD Biotechnologies, a clinical-stage biotech company focused on preventing and treating diseases caused by Bordetella pertussis and other respiratory pathogens, announced that the U.K. Medicines & Healthcare Products Regulatory Agency (MHRA) has granted its BPZE1 next-generation intranasal pertussis vaccine the…
Henry Schein Unveils New Technology at Greater New York Dental Meeting
Henry Schein, Inc. (Nasdaq: HSIC) is showcasing a comprehensive range of dental solutions at the 2024 Greater New York Dental Meeting (GNYDM), taking place at the Henry Schein Dental (#4215) and Henry Schein One (#4022) booths. These solutions are designed…
Honoring Employee Giving and Volunteerism
This giving season, we’re proud to highlight the incredible generosity of our employees who dedicate their time, talents, and financial resources to support and strengthen the communities where we live and work. “At Cardinal Health, we have a strong commitment…
CVS Health Names New Pharmacy and Consumer Wellness Leaders
CVS Health® (NYSE: CVS) has announced key leadership changes within its Pharmacy and Consumer Wellness (PCW) division. Len Shankman has been appointed president of PCW, reporting to Prem Shah, group president of CVS Health. Lucille Accetta, RPh, MPH, MBA, has…
CVS Health Announces Cash Tender Offers for Select Notes
CVS Health Corporation (NYSE: CVS) has announced the commencement of cash tender offers for certain outstanding senior notes. These tender offers are being made for two categories of notes: the 4.100% Senior Notes due 2025 and a selection of additional…